Asia Pacific Digital Pathology Market Size & Outlook
The digital pathology market in Asia Pacific is expected to reach a projected revenue of US$ 695.3 million by 2033. A compound annual growth rate of 9.8% is expected of Asia Pacific digital pathology market from 2025 to 2033.
The Asia Pacific digital pathology market generated a revenue of USD 297.5 million in 2024.
The market is expected to grow at a CAGR of 9.8% from 2025 to 2033.
In terms of segment, software was the largest revenue generating product in 2024.
Software is the most lucrative product segment registering the fastest growth during the forecast period.
Country-wise, India is expected to register the highest CAGR from 2025 to 2033.
Asia Pacific data book summary
Market revenue in 2024
USD 297.5 million
Market revenue in 2033
USD 695.3 million
Growth rate
9.8% (CAGR from 2025 to 2033)
Largest segment
Software
Fastest growing segment
Software
Historical data covered
2021 - 2023
Base year for estimation
2024
Forecast period covered
2025 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Software, Device, Storage Systems
Key market players worldwide
Danaher Corp, Hamamatsu Photonics KK, Koninklijke Philips NV, Olympus Corp, Roche Holding AG ADR, McCormick & Co Inc Registered Shs Non Vtg, Inspire Medical Systems Inc, PHC Holdings Corp, Huron Consulting Group Inc, CellaVision AB Bearer Shs, IBEX Ltd, Morphic Holding Inc, Nuvation Bio Inc Ordinary Shares - Class A
Other key industry trends
In terms of revenue, Asia Pacific region accounted for 21.3% of the global digital pathology market in 2024.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 695.3 million by 2033.
The Asia pacific market is anticipated to register highest growth in the digital pathology market owing to factors such as growing awareness of digital pathology and its benefits, rise in personal disposable income, collaborative efforts by health department, and market players encouraging the use of digital pathology to improve the quality of cancer diagnosis in this region.
Asia Pacific region holds the highest mortality rate, followed by North America. According to the American Cancer Society, Inc., in 2018, it was estimated that around 8 million new cases of cancer and around 5 million deaths occurred due to cancer in Southern, Eastern, and South Eastern Asia.
Regionally, Asia Pacific has highly influenced the digital pathology market due to high incidences of cancer affecting a large population base. Also, increasing demand for novel treatment options, better patient care facilities and reduction in laboratory expenses are further expected to drive the market growth over the coming seven years.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Digital Pathology Market Outlook will help companies and investors design strategic landscapes.
Software was the largest segment with a revenue share of 47.53% in 2024.
Horizon Databook has segmented the Asia Pacific digital pathology market based on software, device, storage systems covering the revenue growth of each sub-segment from 2021 to 2033.
The Asia pacific market is anticipated to register highest growth in the digital pathology market owing to factors such as growing awareness of digital pathology and its benefits, rise in personal disposable income, collaborative efforts by health department, and market players encouraging the use of digital pathology to improve the quality of cancer diagnosis in this region.
Asia Pacific region holds the highest mortality rate, followed by North America. According to the American Cancer Society, Inc., in 2018, it was estimated that around 8 million new cases of cancer and around 5 million deaths occurred due to cancer in Southern, Eastern, and South Eastern Asia.
Regionally, Asia Pacific has highly influenced the digital pathology market due to high incidences of cancer affecting a large population base. Also, increasing demand for novel treatment options, better patient care facilities and reduction in laboratory expenses are further expected to drive the market growth over the coming seven years.
Asia Pacific Digital Pathology Market Product Outlook (Revenue, USD Million , 2021-2033)
Software
Device
Storage Systems
Asia Pacific Digital Pathology Market Application Outlook (Revenue, USD Million , 2021-2033)
Drug Discovery & Development
Academic Research
Disease Diagnostics
Asia Pacific Digital Pathology Market End-Use Outlook (Revenue, USD Million , 2021-2033)
Hospitals
Biotech & Pharmaceutical Companies
Diagnostic Labs
Academic & Research Institutes
Asia Pacific Digital Pathology Market Type Outlook (Revenue, USD Million , 2021-2033)
Human Pathology
Veterinary Pathology
Reasons to subscribe to Digital Pathology Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Digital Pathology Market Outlook databook
Our clientele includes a mix of Digital Pathology Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific Digital Pathology Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific Digital Pathology Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Asia Pacific Digital Pathology Market, 2021-2033 (US$M)